ClinicalTrials.Veeva

Menu

Evaluation of the SmartBx System for Breast Biopsy

U

UC-Care Medical Systems

Status

Completed

Conditions

Breast Cancer

Treatments

Device: SmartBx

Study type

Interventional

Funder types

Industry

Identifiers

NCT03808116
EMC-0124-18

Details and patient eligibility

About

Performance evaluation of a novel, semi-automated device and method for needle core biopsy download compared to standard methods in terms of:

  1. Biopsy core length obtained (i.e. collecting all tissue fragments) 4. Biopsy core yield (i.e. percent of tissue loss during the pathologic processing)

Full description

Examination procedure:

  • Biopsy cores will be collected from the breast during US guided biopsy procedure.

  • The number of cores taken will be decided per the physician discretion according to the clinical demand.

  • Additional two biopsy core will be taken the SmartBx cassette. Since the SmartBx cassette holds two biopsies together, two consecutive cores will be collected using the SmartBx.

  • samples will be photographed for measurements in 2 steps during the process:

    1. On the needle notch [A].
    2. On the glass slide [B].
  • Standard tissue fixation, processing of the samples in paraffin will be performed unchanged per the pathology laboratory protocols.

  • Embedding of the biopsy cores taken with the SmartBx will be embedded using the SmartBx mold and tamper.

  • Standard staining and histology analysis will be preformed to the sectioned samples, unchanged per the pathology protocols.

    • Analysis will be preformed to the histological results, and a comparison between the standard procedures samples to the SmartBx samples will be performed in terms of -

  • Biopsy core length obtained (i.e. collecting all tissue fragments)

  • Biopsy core yield (i.e. percent of tissue loss during the pathologic processing)

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 years or older
  • Planned for breast biopsy procedure.
  • Signed informed consent.

Exclusion criteria

o Patient's unwilling to participate.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

SmartBx biopsy collection
Experimental group
Description:
* Biopsy cores will be collected from the breast during US guided biopsy procedure. * The number of cores taken will be decided per the physician discretion according to the clinical demand. * Additional two biopsy core will be taken the SmartBx cassette
Treatment:
Device: SmartBx

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems